Skip to main content
Fig. 1 | Journal for ImmunoTherapy of Cancer

Fig. 1

From: A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia

Fig. 1

Average natural killer (NK) cell engraftment (a) in peripheral blood plotted over time. KIR–HLA-mismatched NK cells expanded over time in 17 patients (b) and contracted in 4 patients (c). Donor NK cell chimerism was detected in 18 patients (d, gray line), of which 4 were noted to have rising levels over time (black line)

Back to article page